Suppr超能文献

StAR 蛋白 N 端线粒体靶向序列的独特显性负突变,导致一种变异型先天性脂质性肾上腺增生症。

Unique dominant negative mutation in the N-terminal mitochondrial targeting sequence of StAR, causing a variant form of congenital lipoid adrenal hyperplasia.

机构信息

Endocrine Service, Hospital de Pediatria Garrahan, Buenos Aires C1245AAM, Argentina.

出版信息

J Clin Endocrinol Metab. 2013 Jan;98(1):E153-61. doi: 10.1210/jc.2012-2865. Epub 2012 Nov 21.

Abstract

CONTEXT

Steroid acute regulatory (StAR) protein is a mitochondria-targeted protein that is part of the transduceosome complex crucial for transport of cholesterol to mitochondria. Recessive mutations cause classic and nonclassic congenital lipoid adrenal hyperplasia.

OBJECTIVE

The aim of this study was to report the clinical, hormonal, genetic, and functional data of a novel heterozygous mutation in the StAR gene found in a 46,XY patient with ambiguous genitalia and neonatal severe steroidogenic deficiency.

PATIENT

Undetectable serum steroids with high ACTH and plasma renin activity but normal acute GnRH response were found in infancy. After gonadectomy (at 3 yr of age), serum LH and testosterone were undetectable, whereas FSH was normal but increased slowly afterward. Estrogen replacement therapy, started at 10.2 yr of age, suppressed gonadotropins (for 2 yr). However, after 1 month off estrogens, the patient showed castrated levels. At 11.9 yr old, after fludrocortisone withdrawal because of hypertension, plasma renin activity and aldosterone remained normal, suggesting mineralocorticoid recovery by a StAR-independent mechanism.

RESULTS

We found a de novo heterozygous IVS-2A>G StAR mutation and the reported heterozygous p.G146A SF1 polymorphism with normal CYP11A1, FDXR, FDX1, VDAC1, and TSPO genes. The mutant StAR transcript lacked exon 2, resulting in the in-frame loss of amino acids 22 to 59 in the N-terminal mitochondrial targeting signal. In vitro, the mutant protein exhibited reduced StAR activity in a dominant-negative manner and almost no mitochondria localization.

CONCLUSIONS

A misfolded p.G22_L59del StAR might interfere with wild-type StAR activity by blocking the transduceosome complex, causing an autosomal dominant form of StAR deficiency, explaining the clinical phenotype. We speculated that estrogen might have modulated mineralocorticoid function and pubertal maturation in a human natural model lacking endogenous steroid production.

摘要

背景

固醇急性调节蛋白(StAR)是一种定位于线粒体的蛋白质,是胆固醇向线粒体转运所必需的转位体复合物的一部分。隐性突变导致经典和非经典先天性脂肪肾上腺增生。

目的

本研究旨在报告在一名 46,XY 具有性别不明生殖器和新生儿严重类固醇生成缺陷的患者中发现的 StAR 基因的新型杂合突变的临床、激素、遗传和功能数据。

患者

在婴儿期发现血清类固醇无法检测,ACTH 和血浆肾素活性高,但急性 GnRH 反应正常。在性腺切除术(3 岁时)后,血清 LH 和睾酮无法检测,而 FSH 正常,但随后缓慢增加。雌激素替代治疗于 10.2 岁开始,抑制了促性腺激素(2 年)。然而,停止雌激素治疗 1 个月后,患者表现出去势水平。在 11.9 岁时,由于高血压停用氟氢可的松后,血浆肾素活性和醛固酮保持正常,表明通过 StAR 非依赖性机制恢复了盐皮质激素。

结果

我们发现了一个新的杂合性 IVS-2A>G StAR 突变和报道的杂合性 p.G146A SF1 多态性,伴有正常的 CYP11A1、FDXR、FDX1、VDAC1 和 TSPO 基因。突变 StAR 转录物缺失外显子 2,导致 N 端线粒体靶向信号中氨基酸 22 至 59 的框内缺失。在体外,突变蛋白以显性负性方式表现出降低的 StAR 活性,几乎没有线粒体定位。

结论

一种错误折叠的 p.G22_L59del StAR 可能通过阻断转位体复合物干扰野生型 StAR 活性,导致 StAR 缺乏的常染色体显性形式,解释了临床表型。我们推测,雌激素可能在缺乏内源性类固醇产生的人类自然模型中调节盐皮质激素功能和青春期成熟。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验